Synopsis
Synopsis
0
KDMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloroxacillin
2. Cloxacillin
3. Cloxacillin Sodium
4. Cloxacillin, Sodium
5. Sodium Cloxacillin
6. Sodium, Cloxacillin
7. Syntarpen
8. Tegopen
1. Cloxacillin Sodium
2. 7081-44-9
3. Cloxacillin Sodium Monohydrate
4. Bactopen
5. Sodium Cloxacillin Monohydrate
6. Tegopen
7. Orbenin
8. Cloxacillin Sodium Hydrate
9. Ekvacillin
10. Latocillin
11. Cloxypen
12. Methocillin-s
13. Cloxacillin Sodium Salt Monohydrate
14. Cloxacillin (sodium Monohydrate)
15. Cloxacillin (as Sodium)
16. Brl-1621
17. P-25
18. 65lcb00b4y
19. Chebi:34978
20. Monosodium (2s,5r,6r)-6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Monohydrate
21. Sodium (2s,5r,6r)-6-(3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
22. Sodium;(2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
23. Staphobristol-250
24. Orbenin Sodium Hydrate
25. Cloxacap
26. Prostaphlin-a Monohydrate
27. Brl-1621 Sodium Salt Monohydrate
28. Unii-65lcb00b4y
29. Cloxacillin Nataarium-1-wasser
30. Cloxapen (tn)
31. Tegopen (tn)
32. Cloxacillin Sodium [usan:usp:jan]
33. 642-78-4
34. Cloxacillin Sodium (usp)
35. Schembl41012
36. Chembl1200388
37. Cloxacillin Sodium [usan]
38. Dtxsid60110018
39. Cloxacillin Sodium [vandf]
40. Bcp13532
41. Cloxacillin Sodium [usp-rs]
42. Cloxacillin Sodium [who-dd]
43. Cloxacillin Sodium [who-ip]
44. Cloxacillin Sodium Hydrate (jp17)
45. Hy-b0466
46. Mfcd00150735
47. S2564
48. Akos015896310
49. Akos015962898
50. Ac-7623
51. Ccg-269503
52. Cloxacillin Sodium [green Book]
53. Cloxacillin Sodium [orange Book]
54. Cloxacillin Sodium Hydrate [jan]
55. Cloxacillin Sodium [ep Monograph]
56. Cloxacillin Sodium [usp Impurity]
57. 1,3-dichloro-7-bromoisoquinoline
58. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate, (2s-(2alpha,5alpha,6beta))-
59. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, Sodium Salt, Monohydrate
60. As-60182
61. Cloxacillin Sodium [usp Monograph]
62. D02231
63. Ab01568256_01
64. Cloxacillin Sodium Salt Monohydrate [mi]
65. Q-200886
66. Cloxacillin Sodium Hydrate 100 Microg/ml In Methanol
67. Q27116347
68. Z2574937894
69. Cloxacillin Sodium, Antibiotic For Culture Media Use Only
70. Cloxacillin Sodium, European Pharmacopoeia (ep) Reference Standard
71. Cloxacillin Sodium Salt Monohydrate, Beta-lactamase-resistant Antibiotic
72. Cloxacillin Sodium Salt Monohydrate, Vetranal(tm), Analytical Standard
73. Cloxacillin Sodium, United States Pharmacopeia (usp) Reference Standard
74. Cloxacillin Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
76. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate, (2s-(2.alpha.,5.alpha.,6.beta.))-
77. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, Sodium Salt, Hydrate (1:1:1), (2s,5r,6r)-
78. Sodium (2s,5r,6r)-6-[[3-(2-chlorophenyl)-5-methyl1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
79. Sodium (2s,5r,6r)-6-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
80. Sodium 2,2-dimethyl-6beta-({[5-methyl-3-(2-chlorophenyl)isoxazol-4-yl]carbonyl}amino)penam-3alpha-carboxylate Hydrate
1. 642-78-4
2. Cloxacillin Sodium Anhydrous
3. Sodium Orbenin
4. Syntarpen Sodium Salt
5. Monosodium Cloxacillin
6. Sodium Syntarpen
7. Austrastaph
8. Staphybiotic
9. Ankerbin
10. Ekvacillin
11. Gelstaph
12. Cloxacillin Sodium Salt
| Molecular Weight | 475.9 g/mol |
|---|---|
| Molecular Formula | C19H19ClN3NaO6S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 475.0580785 g/mol |
| Monoisotopic Mass | 475.0580785 g/mol |
| Topological Polar Surface Area | 142 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 728 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
Cloxacillin Sodium Monohydrate
About the Company : Bioquim is a European company specializing in bulk oral & sterile APIs for the pharmaceutical industry. With over 40 years of experience, we offer high-quality corticosteroids, pep...
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
About the Company : Established in 1869, Centrient Pharmaceuticals is a global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. Together with tablets, capsul...
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formula...
About the Company : We are pharma manufacturing and API trading service which runs round the clock manufacturing services. We strive to deliver the best value to our customers to ever improving servic...
About the Company : We consider our mission to offer pharmaceutical products of high quality at competitive prices and continuously endeavour to build Mutual Trust with our customers, which is a prere...
About the Company : Rajasthan Antibiotics Limited (RAL-Life) is a fast track integrated pharmaceutical company which commenced its commercial production in 1991 and has grown in size and stature to b...
About the Company : As a professional pharmaceutical manufacturer, Reyoung Pharm. is the first enterprise to manufacture powder for injection in Shandong province. At present, Reyoung Pharm. has the m...
About the Company : Sichuan Renan Pharmaceutical Co., Ltd., founded in June 2013 with 325 acres and more than 1000 employees , located in Yuechi Pharmaceutical Industrial Park, Guangan city Sichuan pr...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Ampiclox 500
Dosage Form : SUS
Dosage Strength : 250mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megamox
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Ampicillin 250Mg & Cloxacillin 250Mg
Brand Name : Cloxam
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cloxam
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cloxam
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cloxin
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cloxin
Dosage Form : CAP
Dosage Strength : 500mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megamox S
Dosage Form : SUS
Dosage Strength : 125mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Injection/Infusion
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2023
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Injection/Infusion
Dosage Strength : 2000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2023
Registration Country : Poland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution fo...
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Available
Dosage : Powder for Solution fo...
Dosage Strength : 1000MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q4 2023
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution fo...
Dosage Strength : 2000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q4 2023
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q4 2023
Dosage : Powder for Solution fo...
Dosage Strength : 2000MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Regulatory Info :
Registration Country : India
Amoxicillin Trihydrate; Cloxacillin Sodium
Brand Name : Amoxycillin;Cloxacilli...
Dosage Form : Dry Powder Injectable
Dosage Strength : 2.5GM; 2.5GM
Packaging : 10ml, 30ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 10ml, 30ml
Regulatory Info :
Amoxicillin Trihydrate; Cloxacillin Sodium
Dosage : Dry Powder Injectable
Dosage Strength : 2.5GM; 2.5GM
Brand Name : Amoxycillin;Cloxacilli...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Oral Suspension
Dosage Strength : 600|MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Bottle
Regulatory Info :
Dosage : Oral Suspension
Dosage Strength : 600|MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 500MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Vial
Regulatory Info :
Dosage : Injection
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Injection
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Ampimex
Dosage Form : Capsule
Dosage Strength : 250MG; 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 250MG; 250MG
Brand Name : Ampimex
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Amoxicillin Trihydrate; Cloxacillin Sodium
Brand Name :
Dosage Form : Capsule
Dosage Strength : 250MG; 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Amoxicillin Trihydrate; Cloxacillin Sodium
Dosage : Capsule
Dosage Strength : 250MG; 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Cloxacillin
Dosage Form : Dry Powder Injection
Dosage Strength : 1GM
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : Vial
Regulatory Info :
Dosage : Dry Powder Injection
Dosage Strength : 1GM
Brand Name : Cloxacillin
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
EDQM
CAS Number : 1847-24-1
Quantity Per Vial : 250 mg
Sale Unit : 1
Order Code : F0150000
Batch No : 8
Price (€) : 79
Storage : -20°C ± 5°C
CAS Number : 13412-64-1
Quantity Per Vial : 250 mg
Sale Unit : 1
Order Code : D1050000
Batch No : 5
Price (€) : 79
Storage : -20°C ± 5°C
CAS Number : 7081-44-9
Quantity Per Vial : 230 mg
Sale Unit : 1
Order Code : C2450000
Batch No : 5
Price (€) : 79
Storage : +5°C ± 3°C
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]USP
USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.
CAS Number : 1642559-64-5
Quantity Per Vial :
Price ($) : 1300
Catalog Number : 1A08070
Current Lot :
Previous Lot :
NDC Code :
ABOUT THIS PAGE
12
PharmaCompass offers a list of Cloxacillin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier.
PharmaCompass also assists you with knowing the Cloxacillin Sodium API Price utilized in the formulation of products. Cloxacillin Sodium API Price is not always fixed or binding as the Cloxacillin Sodium Price is obtained through a variety of data sources. The Cloxacillin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cloxapen;Cloxacap;Orbenin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloxapen;Cloxacap;Orbenin, including repackagers and relabelers. The FDA regulates Cloxapen;Cloxacap;Orbenin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloxapen;Cloxacap;Orbenin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloxapen;Cloxacap;Orbenin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloxapen;Cloxacap;Orbenin supplier is an individual or a company that provides Cloxapen;Cloxacap;Orbenin active pharmaceutical ingredient (API) or Cloxapen;Cloxacap;Orbenin finished formulations upon request. The Cloxapen;Cloxacap;Orbenin suppliers may include Cloxapen;Cloxacap;Orbenin API manufacturers, exporters, distributors and traders.
click here to find a list of Cloxapen;Cloxacap;Orbenin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cloxapen;Cloxacap;Orbenin DMF (Drug Master File) is a document detailing the whole manufacturing process of Cloxapen;Cloxacap;Orbenin active pharmaceutical ingredient (API) in detail. Different forms of Cloxapen;Cloxacap;Orbenin DMFs exist exist since differing nations have different regulations, such as Cloxapen;Cloxacap;Orbenin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cloxapen;Cloxacap;Orbenin DMF submitted to regulatory agencies in the US is known as a USDMF. Cloxapen;Cloxacap;Orbenin USDMF includes data on Cloxapen;Cloxacap;Orbenin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cloxapen;Cloxacap;Orbenin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cloxapen;Cloxacap;Orbenin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cloxapen;Cloxacap;Orbenin Drug Master File in Japan (Cloxapen;Cloxacap;Orbenin JDMF) empowers Cloxapen;Cloxacap;Orbenin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cloxapen;Cloxacap;Orbenin JDMF during the approval evaluation for pharmaceutical products. At the time of Cloxapen;Cloxacap;Orbenin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cloxapen;Cloxacap;Orbenin suppliers with JDMF on PharmaCompass.
A Cloxapen;Cloxacap;Orbenin CEP of the European Pharmacopoeia monograph is often referred to as a Cloxapen;Cloxacap;Orbenin Certificate of Suitability (COS). The purpose of a Cloxapen;Cloxacap;Orbenin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cloxapen;Cloxacap;Orbenin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cloxapen;Cloxacap;Orbenin to their clients by showing that a Cloxapen;Cloxacap;Orbenin CEP has been issued for it. The manufacturer submits a Cloxapen;Cloxacap;Orbenin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cloxapen;Cloxacap;Orbenin CEP holder for the record. Additionally, the data presented in the Cloxapen;Cloxacap;Orbenin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cloxapen;Cloxacap;Orbenin DMF.
A Cloxapen;Cloxacap;Orbenin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cloxapen;Cloxacap;Orbenin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cloxapen;Cloxacap;Orbenin suppliers with CEP (COS) on PharmaCompass.
A Cloxapen;Cloxacap;Orbenin written confirmation (Cloxapen;Cloxacap;Orbenin WC) is an official document issued by a regulatory agency to a Cloxapen;Cloxacap;Orbenin manufacturer, verifying that the manufacturing facility of a Cloxapen;Cloxacap;Orbenin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cloxapen;Cloxacap;Orbenin APIs or Cloxapen;Cloxacap;Orbenin finished pharmaceutical products to another nation, regulatory agencies frequently require a Cloxapen;Cloxacap;Orbenin WC (written confirmation) as part of the regulatory process.
click here to find a list of Cloxapen;Cloxacap;Orbenin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cloxapen;Cloxacap;Orbenin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cloxapen;Cloxacap;Orbenin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cloxapen;Cloxacap;Orbenin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cloxapen;Cloxacap;Orbenin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cloxapen;Cloxacap;Orbenin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cloxapen;Cloxacap;Orbenin suppliers with NDC on PharmaCompass.
Cloxapen;Cloxacap;Orbenin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloxapen;Cloxacap;Orbenin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloxapen;Cloxacap;Orbenin GMP manufacturer or Cloxapen;Cloxacap;Orbenin GMP API supplier for your needs.
A Cloxapen;Cloxacap;Orbenin CoA (Certificate of Analysis) is a formal document that attests to Cloxapen;Cloxacap;Orbenin's compliance with Cloxapen;Cloxacap;Orbenin specifications and serves as a tool for batch-level quality control.
Cloxapen;Cloxacap;Orbenin CoA mostly includes findings from lab analyses of a specific batch. For each Cloxapen;Cloxacap;Orbenin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloxapen;Cloxacap;Orbenin may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloxapen;Cloxacap;Orbenin EP), Cloxapen;Cloxacap;Orbenin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloxapen;Cloxacap;Orbenin USP).
